The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Adapalene is a third generation retinoid used primarily to treat mild to moderate acne, but is also used to treat Keratosis Pilaris and other skin conditions.
The global Adapalene market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Adapalene is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Adapalene is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Adapalene in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Adapalene include Galderma, Glenmark Pharmaceuticals, Fougera Pharmaceuticals, A-S Medication Solutions, Taro Pharmaceuticals, Sandoz Inc., Prasco Laboratories, Actavis Pharma Company and Perrigo, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Adapalene, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adapalene.
Report Scope
The Adapalene market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Adapalene market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adapalene companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Galderma
Glenmark Pharmaceuticals
Fougera Pharmaceuticals
A-S Medication Solutions
Taro Pharmaceuticals
Sandoz Inc.
Prasco Laboratories
Actavis Pharma Company
Perrigo
Physicians Total Care
DPT Laboratories
Tianjin Jinyao Pharmaceutical
Heilongjiang fuhe Pharmaceutical Group
Sichuan Mingxin Pharmaceutical
Hainan Quanxing Pharmaceutical
Jiangsu Zhongdan Pharmaceutical
Jiangsu Fubang Pharmaceutical
Segment by Type
Cream
Gel
Lotion
Segment by Application
Hospital
Compounding Pharmacy
Skin Clinic
Beauty Center
Brick-and-mortar Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adapalene companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Adapalene is a third generation retinoid used primarily to treat mild to moderate acne, but is also used to treat Keratosis Pilaris and other skin conditions.
The global Adapalene market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Adapalene is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Adapalene is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Adapalene in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Adapalene include Galderma, Glenmark Pharmaceuticals, Fougera Pharmaceuticals, A-S Medication Solutions, Taro Pharmaceuticals, Sandoz Inc., Prasco Laboratories, Actavis Pharma Company and Perrigo, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Adapalene, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adapalene.
Report Scope
The Adapalene market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Adapalene market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adapalene companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Galderma
Glenmark Pharmaceuticals
Fougera Pharmaceuticals
A-S Medication Solutions
Taro Pharmaceuticals
Sandoz Inc.
Prasco Laboratories
Actavis Pharma Company
Perrigo
Physicians Total Care
DPT Laboratories
Tianjin Jinyao Pharmaceutical
Heilongjiang fuhe Pharmaceutical Group
Sichuan Mingxin Pharmaceutical
Hainan Quanxing Pharmaceutical
Jiangsu Zhongdan Pharmaceutical
Jiangsu Fubang Pharmaceutical
Segment by Type
Cream
Gel
Lotion
Segment by Application
Hospital
Compounding Pharmacy
Skin Clinic
Beauty Center
Brick-and-mortar Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adapalene companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adapalene Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cream
1.2.3 Gel
1.2.4 Lotion
1.3 Market by Application
1.3.1 Global Adapalene Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Compounding Pharmacy
1.3.4 Skin Clinic
1.3.5 Beauty Center
1.3.6 Brick-and-mortar Pharmacy
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adapalene Market Perspective (2019-2030)
2.2 Adapalene Growth Trends by Region
2.2.1 Global Adapalene Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Adapalene Historic Market Size by Region (2019-2024)
2.2.3 Adapalene Forecasted Market Size by Region (2025-2030)
2.3 Adapalene Market Dynamics
2.3.1 Adapalene Industry Trends
2.3.2 Adapalene Market Drivers
2.3.3 Adapalene Market Challenges
2.3.4 Adapalene Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adapalene Players by Revenue
3.1.1 Global Top Adapalene Players by Revenue (2019-2024)
3.1.2 Global Adapalene Revenue Market Share by Players (2019-2024)
3.2 Global Adapalene Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adapalene Revenue
3.4 Global Adapalene Market Concentration Ratio
3.4.1 Global Adapalene Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adapalene Revenue in 2023
3.5 Adapalene Key Players Head office and Area Served
3.6 Key Players Adapalene Product Solution and Service
3.7 Date of Enter into Adapalene Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adapalene Breakdown Data by Type
4.1 Global Adapalene Historic Market Size by Type (2019-2024)
4.2 Global Adapalene Forecasted Market Size by Type (2025-2030)
5 Adapalene Breakdown Data by Application
5.1 Global Adapalene Historic Market Size by Application (2019-2024)
5.2 Global Adapalene Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Adapalene Market Size (2019-2030)
6.2 North America Adapalene Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Adapalene Market Size by Country (2019-2024)
6.4 North America Adapalene Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Adapalene Market Size (2019-2030)
7.2 Europe Adapalene Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Adapalene Market Size by Country (2019-2024)
7.4 Europe Adapalene Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adapalene Market Size (2019-2030)
8.2 Asia-Pacific Adapalene Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Adapalene Market Size by Region (2019-2024)
8.4 Asia-Pacific Adapalene Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Adapalene Market Size (2019-2030)
9.2 Latin America Adapalene Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Adapalene Market Size by Country (2019-2024)
9.4 Latin America Adapalene Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adapalene Market Size (2019-2030)
10.2 Middle East & Africa Adapalene Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Adapalene Market Size by Country (2019-2024)
10.4 Middle East & Africa Adapalene Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Galderma
11.1.1 Galderma Company Detail
11.1.2 Galderma Business Overview
11.1.3 Galderma Adapalene Introduction
11.1.4 Galderma Revenue in Adapalene Business (2019-2024)
11.1.5 Galderma Recent Development
11.2 Glenmark Pharmaceuticals
11.2.1 Glenmark Pharmaceuticals Company Detail
11.2.2 Glenmark Pharmaceuticals Business Overview
11.2.3 Glenmark Pharmaceuticals Adapalene Introduction
11.2.4 Glenmark Pharmaceuticals Revenue in Adapalene Business (2019-2024)
11.2.5 Glenmark Pharmaceuticals Recent Development
11.3 Fougera Pharmaceuticals
11.3.1 Fougera Pharmaceuticals Company Detail
11.3.2 Fougera Pharmaceuticals Business Overview
11.3.3 Fougera Pharmaceuticals Adapalene Introduction
11.3.4 Fougera Pharmaceuticals Revenue in Adapalene Business (2019-2024)
11.3.5 Fougera Pharmaceuticals Recent Development
11.4 A-S Medication Solutions
11.4.1 A-S Medication Solutions Company Detail
11.4.2 A-S Medication Solutions Business Overview
11.4.3 A-S Medication Solutions Adapalene Introduction
11.4.4 A-S Medication Solutions Revenue in Adapalene Business (2019-2024)
11.4.5 A-S Medication Solutions Recent Development
11.5 Taro Pharmaceuticals
11.5.1 Taro Pharmaceuticals Company Detail
11.5.2 Taro Pharmaceuticals Business Overview
11.5.3 Taro Pharmaceuticals Adapalene Introduction
11.5.4 Taro Pharmaceuticals Revenue in Adapalene Business (2019-2024)
11.5.5 Taro Pharmaceuticals Recent Development
11.6 Sandoz Inc.
11.6.1 Sandoz Inc. Company Detail
11.6.2 Sandoz Inc. Business Overview
11.6.3 Sandoz Inc. Adapalene Introduction
11.6.4 Sandoz Inc. Revenue in Adapalene Business (2019-2024)
11.6.5 Sandoz Inc. Recent Development
11.7 Prasco Laboratories
11.7.1 Prasco Laboratories Company Detail
11.7.2 Prasco Laboratories Business Overview
11.7.3 Prasco Laboratories Adapalene Introduction
11.7.4 Prasco Laboratories Revenue in Adapalene Business (2019-2024)
11.7.5 Prasco Laboratories Recent Development
11.8 Actavis Pharma Company
11.8.1 Actavis Pharma Company Company Detail
11.8.2 Actavis Pharma Company Business Overview
11.8.3 Actavis Pharma Company Adapalene Introduction
11.8.4 Actavis Pharma Company Revenue in Adapalene Business (2019-2024)
11.8.5 Actavis Pharma Company Recent Development
11.9 Perrigo
11.9.1 Perrigo Company Detail
11.9.2 Perrigo Business Overview
11.9.3 Perrigo Adapalene Introduction
11.9.4 Perrigo Revenue in Adapalene Business (2019-2024)
11.9.5 Perrigo Recent Development
11.10 Physicians Total Care
11.10.1 Physicians Total Care Company Detail
11.10.2 Physicians Total Care Business Overview
11.10.3 Physicians Total Care Adapalene Introduction
11.10.4 Physicians Total Care Revenue in Adapalene Business (2019-2024)
11.10.5 Physicians Total Care Recent Development
11.11 DPT Laboratories
11.11.1 DPT Laboratories Company Detail
11.11.2 DPT Laboratories Business Overview
11.11.3 DPT Laboratories Adapalene Introduction
11.11.4 DPT Laboratories Revenue in Adapalene Business (2019-2024)
11.11.5 DPT Laboratories Recent Development
11.12 Tianjin Jinyao Pharmaceutical
11.12.1 Tianjin Jinyao Pharmaceutical Company Detail
11.12.2 Tianjin Jinyao Pharmaceutical Business Overview
11.12.3 Tianjin Jinyao Pharmaceutical Adapalene Introduction
11.12.4 Tianjin Jinyao Pharmaceutical Revenue in Adapalene Business (2019-2024)
11.12.5 Tianjin Jinyao Pharmaceutical Recent Development
11.13 Heilongjiang fuhe Pharmaceutical Group
11.13.1 Heilongjiang fuhe Pharmaceutical Group Company Detail
11.13.2 Heilongjiang fuhe Pharmaceutical Group Business Overview
11.13.3 Heilongjiang fuhe Pharmaceutical Group Adapalene Introduction
11.13.4 Heilongjiang fuhe Pharmaceutical Group Revenue in Adapalene Business (2019-2024)
11.13.5 Heilongjiang fuhe Pharmaceutical Group Recent Development
11.14 Sichuan Mingxin Pharmaceutical
11.14.1 Sichuan Mingxin Pharmaceutical Company Detail
11.14.2 Sichuan Mingxin Pharmaceutical Business Overview
11.14.3 Sichuan Mingxin Pharmaceutical Adapalene Introduction
11.14.4 Sichuan Mingxin Pharmaceutical Revenue in Adapalene Business (2019-2024)
11.14.5 Sichuan Mingxin Pharmaceutical Recent Development
11.15 Hainan Quanxing Pharmaceutical
11.15.1 Hainan Quanxing Pharmaceutical Company Detail
11.15.2 Hainan Quanxing Pharmaceutical Business Overview
11.15.3 Hainan Quanxing Pharmaceutical Adapalene Introduction
11.15.4 Hainan Quanxing Pharmaceutical Revenue in Adapalene Business (2019-2024)
11.15.5 Hainan Quanxing Pharmaceutical Recent Development
11.16 Jiangsu Zhongdan Pharmaceutical
11.16.1 Jiangsu Zhongdan Pharmaceutical Company Detail
11.16.2 Jiangsu Zhongdan Pharmaceutical Business Overview
11.16.3 Jiangsu Zhongdan Pharmaceutical Adapalene Introduction
11.16.4 Jiangsu Zhongdan Pharmaceutical Revenue in Adapalene Business (2019-2024)
11.16.5 Jiangsu Zhongdan Pharmaceutical Recent Development
11.17 Jiangsu Fubang Pharmaceutical
11.17.1 Jiangsu Fubang Pharmaceutical Company Detail
11.17.2 Jiangsu Fubang Pharmaceutical Business Overview
11.17.3 Jiangsu Fubang Pharmaceutical Adapalene Introduction
11.17.4 Jiangsu Fubang Pharmaceutical Revenue in Adapalene Business (2019-2024)
11.17.5 Jiangsu Fubang Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Adapalene Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Cream
Table 3. Key Players of Gel
Table 4. Key Players of Lotion
Table 5. Global Adapalene Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Adapalene Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Adapalene Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Adapalene Market Share by Region (2019-2024)
Table 9. Global Adapalene Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Adapalene Market Share by Region (2025-2030)
Table 11. Adapalene Market Trends
Table 12. Adapalene Market Drivers
Table 13. Adapalene Market Challenges
Table 14. Adapalene Market Restraints
Table 15. Global Adapalene Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Adapalene Market Share by Players (2019-2024)
Table 17. Global Top Adapalene Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adapalene as of 2023)
Table 18. Ranking of Global Top Adapalene Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Adapalene Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Adapalene Product Solution and Service
Table 22. Date of Enter into Adapalene Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Adapalene Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Adapalene Revenue Market Share by Type (2019-2024)
Table 26. Global Adapalene Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Adapalene Revenue Market Share by Type (2025-2030)
Table 28. Global Adapalene Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Adapalene Revenue Market Share by Application (2019-2024)
Table 30. Global Adapalene Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Adapalene Revenue Market Share by Application (2025-2030)
Table 32. North America Adapalene Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Adapalene Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Adapalene Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Adapalene Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Adapalene Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Adapalene Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Adapalene Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Adapalene Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Adapalene Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Adapalene Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Adapalene Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Adapalene Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Adapalene Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Adapalene Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Adapalene Market Size by Country (2025-2030) & (US$ Million)
Table 47. Galderma Company Detail
Table 48. Galderma Business Overview
Table 49. Galderma Adapalene Product
Table 50. Galderma Revenue in Adapalene Business (2019-2024) & (US$ Million)
Table 51. Galderma Recent Development
Table 52. Glenmark Pharmaceuticals Company Detail
Table 53. Glenmark Pharmaceuticals Business Overview
Table 54. Glenmark Pharmaceuticals Adapalene Product
Table 55. Glenmark Pharmaceuticals Revenue in Adapalene Business (2019-2024) & (US$ Million)
Table 56. Glenmark Pharmaceuticals Recent Development
Table 57. Fougera Pharmaceuticals Company Detail
Table 58. Fougera Pharmaceuticals Business Overview
Table 59. Fougera Pharmaceuticals Adapalene Product
Table 60. Fougera Pharmaceuticals Revenue in Adapalene Business (2019-2024) & (US$ Million)
Table 61. Fougera Pharmaceuticals Recent Development
Table 62. A-S Medication Solutions Company Detail
Table 63. A-S Medication Solutions Business Overview
Table 64. A-S Medication Solutions Adapalene Product
Table 65. A-S Medication Solutions Revenue in Adapalene Business (2019-2024) & (US$ Million)
Table 66. A-S Medication Solutions Recent Development
Table 67. Taro Pharmaceuticals Company Detail
Table 68. Taro Pharmaceuticals Business Overview
Table 69. Taro Pharmaceuticals Adapalene Product
Table 70. Taro Pharmaceuticals Revenue in Adapalene Business (2019-2024) & (US$ Million)
Table 71. Taro Pharmaceuticals Recent Development
Table 72. Sandoz Inc. Company Detail
Table 73. Sandoz Inc. Business Overview
Table 74. Sandoz Inc. Adapalene Product
Table 75. Sandoz Inc. Revenue in Adapalene Business (2019-2024) & (US$ Million)
Table 76. Sandoz Inc. Recent Development
Table 77. Prasco Laboratories Company Detail
Table 78. Prasco Laboratories Business Overview
Table 79. Prasco Laboratories Adapalene Product
Table 80. Prasco Laboratories Revenue in Adapalene Business (2019-2024) & (US$ Million)
Table 81. Prasco Laboratories Recent Development
Table 82. Actavis Pharma Company Company Detail
Table 83. Actavis Pharma Company Business Overview
Table 84. Actavis Pharma Company Adapalene Product
Table 85. Actavis Pharma Company Revenue in Adapalene Business (2019-2024) & (US$ Million)
Table 86. Actavis Pharma Company Recent Development
Table 87. Perrigo Company Detail
Table 88. Perrigo Business Overview
Table 89. Perrigo Adapalene Product
Table 90. Perrigo Revenue in Adapalene Business (2019-2024) & (US$ Million)
Table 91. Perrigo Recent Development
Table 92. Physicians Total Care Company Detail
Table 93. Physicians Total Care Business Overview
Table 94. Physicians Total Care Adapalene Product
Table 95. Physicians Total Care Revenue in Adapalene Business (2019-2024) & (US$ Million)
Table 96. Physicians Total Care Recent Development
Table 97. DPT Laboratories Company Detail
Table 98. DPT Laboratories Business Overview
Table 99. DPT Laboratories Adapalene Product
Table 100. DPT Laboratories Revenue in Adapalene Business (2019-2024) & (US$ Million)
Table 101. DPT Laboratories Recent Development
Table 102. Tianjin Jinyao Pharmaceutical Company Detail
Table 103. Tianjin Jinyao Pharmaceutical Business Overview
Table 104. Tianjin Jinyao Pharmaceutical Adapalene Product
Table 105. Tianjin Jinyao Pharmaceutical Revenue in Adapalene Business (2019-2024) & (US$ Million)
Table 106. Tianjin Jinyao Pharmaceutical Recent Development
Table 107. Heilongjiang fuhe Pharmaceutical Group Company Detail
Table 108. Heilongjiang fuhe Pharmaceutical Group Business Overview
Table 109. Heilongjiang fuhe Pharmaceutical Group Adapalene Product
Table 110. Heilongjiang fuhe Pharmaceutical Group Revenue in Adapalene Business (2019-2024) & (US$ Million)
Table 111. Heilongjiang fuhe Pharmaceutical Group Recent Development
Table 112. Sichuan Mingxin Pharmaceutical Company Detail
Table 113. Sichuan Mingxin Pharmaceutical Business Overview
Table 114. Sichuan Mingxin Pharmaceutical Adapalene Product
Table 115. Sichuan Mingxin Pharmaceutical Revenue in Adapalene Business (2019-2024) & (US$ Million)
Table 116. Sichuan Mingxin Pharmaceutical Recent Development
Table 117. Hainan Quanxing Pharmaceutical Company Detail
Table 118. Hainan Quanxing Pharmaceutical Business Overview
Table 119. Hainan Quanxing Pharmaceutical Adapalene Product
Table 120. Hainan Quanxing Pharmaceutical Revenue in Adapalene Business (2019-2024) & (US$ Million)
Table 121. Hainan Quanxing Pharmaceutical Recent Development
Table 122. Jiangsu Zhongdan Pharmaceutical Company Detail
Table 123. Jiangsu Zhongdan Pharmaceutical Business Overview
Table 124. Jiangsu Zhongdan Pharmaceutical Adapalene Product
Table 125. Jiangsu Zhongdan Pharmaceutical Revenue in Adapalene Business (2019-2024) & (US$ Million)
Table 126. Jiangsu Zhongdan Pharmaceutical Recent Development
Table 127. Jiangsu Fubang Pharmaceutical Company Detail
Table 128. Jiangsu Fubang Pharmaceutical Business Overview
Table 129. Jiangsu Fubang Pharmaceutical Adapalene Product
Table 130. Jiangsu Fubang Pharmaceutical Revenue in Adapalene Business (2019-2024) & (US$ Million)
Table 131. Jiangsu Fubang Pharmaceutical Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adapalene Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Adapalene Market Share by Type: 2023 VS 2030
Figure 3. Cream Features
Figure 4. Gel Features
Figure 5. Lotion Features
Figure 6. Global Adapalene Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Adapalene Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Compounding Pharmacy Case Studies
Figure 10. Skin Clinic Case Studies
Figure 11. Beauty Center Case Studies
Figure 12. Brick-and-mortar Pharmacy Case Studies
Figure 13. Other Case Studies
Figure 14. Adapalene Report Years Considered
Figure 15. Global Adapalene Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Adapalene Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Adapalene Market Share by Region: 2023 VS 2030
Figure 18. Global Adapalene Market Share by Players in 2023
Figure 19. Global Top Adapalene Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adapalene as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Adapalene Revenue in 2023
Figure 21. North America Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Adapalene Market Share by Country (2019-2030)
Figure 23. United States Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Adapalene Market Share by Country (2019-2030)
Figure 27. Germany Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Adapalene Market Share by Region (2019-2030)
Figure 35. China Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Adapalene Market Share by Country (2019-2030)
Figure 43. Mexico Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Adapalene Market Share by Country (2019-2030)
Figure 47. Turkey Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Adapalene Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Galderma Revenue Growth Rate in Adapalene Business (2019-2024)
Figure 50. Glenmark Pharmaceuticals Revenue Growth Rate in Adapalene Business (2019-2024)
Figure 51. Fougera Pharmaceuticals Revenue Growth Rate in Adapalene Business (2019-2024)
Figure 52. A-S Medication Solutions Revenue Growth Rate in Adapalene Business (2019-2024)
Figure 53. Taro Pharmaceuticals Revenue Growth Rate in Adapalene Business (2019-2024)
Figure 54. Sandoz Inc. Revenue Growth Rate in Adapalene Business (2019-2024)
Figure 55. Prasco Laboratories Revenue Growth Rate in Adapalene Business (2019-2024)
Figure 56. Actavis Pharma Company Revenue Growth Rate in Adapalene Business (2019-2024)
Figure 57. Perrigo Revenue Growth Rate in Adapalene Business (2019-2024)
Figure 58. Physicians Total Care Revenue Growth Rate in Adapalene Business (2019-2024)
Figure 59. DPT Laboratories Revenue Growth Rate in Adapalene Business (2019-2024)
Figure 60. Tianjin Jinyao Pharmaceutical Revenue Growth Rate in Adapalene Business (2019-2024)
Figure 61. Heilongjiang fuhe Pharmaceutical Group Revenue Growth Rate in Adapalene Business (2019-2024)
Figure 62. Sichuan Mingxin Pharmaceutical Revenue Growth Rate in Adapalene Business (2019-2024)
Figure 63. Hainan Quanxing Pharmaceutical Revenue Growth Rate in Adapalene Business (2019-2024)
Figure 64. Jiangsu Zhongdan Pharmaceutical Revenue Growth Rate in Adapalene Business (2019-2024)
Figure 65. Jiangsu Fubang Pharmaceutical Revenue Growth Rate in Adapalene Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
